Home
Thyrocare Technologies Ltd Board of Directors
Board of Directors at Thyrocare Technologies Ltd
Dharmil Sheth
Non-Exec & Non-Independent Dir
Dhaval Shah
Non-Exec & Non-Independent Dir
GOPAL HEGDE
Independent Director
Hardik Dedhia
Non-Exec & Non-Independent Dir
Harshil Vora
Independent Director
Key Highlights
- Rahul Guha joins the board as Chairman / Executive Director / MD / CEO, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Dharmil Sheth joins the board as Non-Exec & Non-Independent Dir, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Dhaval Shah joins the board as Non-Exec & Non-Independent Dir, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Indumati Gopinathan joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Prapti Ishwar Gilada joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Thyrocare Technologies Ltd
NSE: THYROCARE
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 09 Dec 2025 | 430.05 |
| 08 Dec 2025 | 421.85 |
| 05 Dec 2025 | 410.7 |
| 04 Dec 2025 | 428.1 |
| 03 Dec 2025 | 433 |
| 02 Dec 2025 | 463.8 |
| 01 Dec 2025 | 485.65 |
| 28 Nov 2025 | 495.35 |
| 27 Nov 2025 | 491.3 |
| 26 Nov 2025 | 498.66 |
Company Fundamentals for Thyrocare Technologies Ltd
Market Cap
6,844 Cr
EPS
8.0
P/E Ratio (TTM)
53.6
P/B Ratio (TTM)
12.8
Day’s High
431.65
Day’s Low
413.05
DTE
0.0
ROE
23.9
52 Week High
537.96
52 Week Low
219.33
ROCE
34.1
Market Price of Thyrocare Technologies Ltd
1M
1Y
3Y
5Y
Monitoring Thyrocare Technologies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Thyrocare Technologies Ltd News Hub
Thyrocare Technologies AGM scheduled
Thyrocare Technologies announced that the Annual General Meeting (AGM) of the company will be held o
Read more
06 Aug 24
Thyrocare Tech to acquire diagnostic and pathological services of Vimta Lab
Thyrocare Technologies said that it shall have access to 11 centres of Vimta Labs at the locations s
Read more
30 Aug 24
Thyrocare to acquire diagnostic and pathological services of Vimta Lab
Thyrocare Technologies has signed a Business Transfer Agreement for purchase of the diagnostic and p
Read more
30 Aug 24
Thyrocare Technologies announces cessation of director
Thyrocare Technologies announced the cessation of Neetin Shivajirao Desai (DIN No: 02622364) as Inde
Read more
19 Sept 24
Document
Annual Reports
Annual Report 2024
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
FAQs for Board of Directors of Thyrocare Technologies Ltd
How are members of Thyrocare Technologies Ltd Board of Directors selected?
Members of the Thyrocare Technologies Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Thyrocare Technologies Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Thyrocare Technologies Ltd Board of Directors?
Shareholders can interact with the Thyrocare Technologies Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Thyrocare Technologies Ltd Board of Directors meet?
The Thyrocare Technologies Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Thyrocare Technologies Ltd Board of Directors?
The Thyrocare Technologies Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Thyrocare Technologies Ltd?
The current Board of Directors at Thyrocare Technologies Ltd includes Rahul Guha( Chairman / Executive Director / MD / CEO) ,Dharmil Sheth( Non-Exec & Non-Independent Dir) ,Dhaval Shah( Non-Exec & Non-Independent Dir) ,Indumati Gopinathan( Independent Non Exe. Director) ,Prapti Ishwar Gilada( Independent Non Exe. Director) . The full list can be found on Thyrocare Technologies Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
